Catalyst Event
Johnson & Johnson (JNJ) · Other
From Akros SCHK HK-U.S. Biotech Index (ASHUBIO)
5/13/2026, 12:00:00 AM
Announced the global launch of the next-generation Shockwave C2 Aero coronary intravascular lithotripsy (IVL) catheter on 2026-05-13; price impact estimated at 5% due to market expansion expected.
Korean Translation
2026년 5월 13일 복잡한 석회화 관상동맥 질환 치료를 위한 차세대 쇼크웨이브 C2 에어로 관상동맥 혈관 내 쇄석술(IVL) 카테터의 글로벌 출시를 발표함. 시장 확대에 따라 약 5%의 주가 영향이 예상됨.
Related Recent Events
3SBio Inc (1530) · Earnings Release
First half 2026 earnings results are expected to be released around August 26, 2026, expected. High importance is estimated due to the significant impact of previous earnings growth on stock volatility.
8/26/2026, 12:00:00 AM
3SBio Inc (1530) · Other
The ex-dividend date for the final cash dividend of HKD 0.25 per share for the fiscal year 2025 is July 21, 2026, scheduled.
7/21/2026, 12:00:00 AM
Sino Biopharmaceutical Ltd (1177) · Other
The ex-dividend date for the proposed final dividend of HKD 0.05 per share is 2026-06-24, which is estimated to have a price impact of ≥1% scheduled.
6/24/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Giant Biogene Holding Co Ltd (2367) · Other
Ex-dividend date of 2026-06-01 for final and special dividends, scheduled. (Estimated Low impact as dividend is standard).
6/1/2026, 12:00:00 AM
CSPC Pharmaceutical Group Ltd (1093) · Earnings Release
Q1 2026 earnings release scheduled. Analysts forecast revenue of 7.52B HKD. Estimated Medium importance as earnings results typically drive significant price movement scheduled.
5/27/2026, 12:00:00 AM